Azura Ophthalmics
Acquired- Business Model
- B2B
- Website
- azuraophthalmics.com
- Total Funding
- $36.0M
- Last Round
- $20.0M Series COct 2020
- Rounds
- 3
About
Clinical-stage biotech developing keratolytic therapeutics for ocular surface diseases including dry eye.
Summary
Azura Ophthalmics is a Biotech company. It has raised $36.0M in total across 3 rounds, most recently a $20.0M Series C round in Oct 2020. Investors include OrbiMed, Brandon Capital Partners and TPG Biotech.
Tech & App Stack
4 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Oct 2020
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...